|
The content
The in-depth drug safety conference programme covers the detection, analysis and prevention of adverse drug reactions with case studies and industry experiences as well as global regulatory coverage of developments in the US, Japan, Europe, Asia/Pacific, South America and Canada.
Key topics include Emerging Market Focus, International Regulatory Roundup, Risk Management & Communication, Benefit Risk Decision Making, Signal Reporting & Management, Clinical Safety Strategy, Safety in Early Development and Observational Studies/Post Approval Safety.
» More about the conference
» Download the brochure
|
The speakers
At World Drug Safety Congress Europe you can expect to see speakers from a wide range of countries. There will be case study updates, and we will strive to introduce fresh strategy content as we continue to keep track of the latest developments.
We have representation from Bristol-Myers Squibb, F-Hoffman La Roche, AstraZeneca, Amgen, Abbott, Eisai, Pfizer, Novartis and many more...
» Become a speaker
» Download the brochure
|